398 Journal of Hepatology, 1992; 16:398-399 01992 Elsevier Scientific Publishers Ireland Ltd. All rights reserved. 0168-8278/92/$05.00

Subject Index (Vol. 16)

Acetylcholine, 177 Acute variceal haemorrhage, 128 Adenocarcinoma, 346 Age, 122 Albumin-mediated transport, 38 Alcohol, 290 Alcoholism, 122 Aldosterone, 190 Aminopyrine breath test, 355 Aneuploid, 208 Anti-HBe, 153 Antigen-antibody complex, 106 Antimitochondrial antibodies, 165 Ascites, 59 Ascites turnover, 369 Atrial natriuretic peptide, 190 Autoantibodies, 165 Autonomic nervous system, 177

Bacteriuria, 73 Bile acid therapy, 102 Biliary excretion, 77 Biliary permeability, 89 Biliary reabsorption, 89 Body composition, 59

Carbon tetrachloride, 332 Case control study, 360 Cellular uptake, 304 Cholestasis, 89, 355 Chronic hepatitis, 273, 364 Chronic hepatitis C, 380 Cirrhosis, 31, 73, 122, 190, 290, 369 Cirrhotic ascites, 98 Colchicine, 282 Compartmental model, 369 Connective tissue, 355 Contraction, 326 Copper, 332, 346 Cytochrome P-450, 355

Dilution method, 369 16,16-Dimethyl prostaglandin E,, 282 Diploid, 208 Distal splenorenal shunt, 338 DNA sequencing, 224 Doppler studies, 298 Ductular proliferation, 355

Edema, 59 Encephalopathy, 31 Endocytosis, 115 Endoscopic sclerotherapy, 338 Endothelium, 106 Endotoxin, 266 Energy expenditure, 145 Ethanol, 316 Extrahepatic portal hypertension, 215

Fc-receptor, 106 Flow cytometry, 208 Free fatty acids, 304

Galactosamine, 332 Gallstone, 102 Genetic hemochromatosis, 122

Haemochromatosis, 351 Haplotype, 316 HBeAg, 153 HBsAg, 360 HBV-DNA, 184 HCV-RNA, 138, 184, 364 HDAg, 153 Hepatic cirrhosis, 59 Hepatic fibrosis, 122, 316 Hepatic macrophage, 171 Hepatitis, 290 Hepatitis B virus, 224 Hepatitis C, 138, 273 Hepatitis C virus, 56, 219, 360, 380 Hepatitis transmission, 56 Hepatocellular carcinoma, 66, 360 Hepatocytes, 219, 228, 304, 355 HIV, 219 Human tumor-infiltrating lymphocytes, 197 Hypertension, portal, 298

Immune modulators, 228 Immune response, 228 Immunoblotting, 165 Immunofluorescence, 153 Injection sclerotherapy, 128 In situ hybridization, 219 Insulin resistance, 145 Interferon, 138, 380 Interleukin-l, 228 In vitro antibody production, 165 Iron damage, 364 Iron overload, 122, 364 Ischemia-reperfusion, 376

Kallikrein heavy chain, 115

Liver cirrhosis, 177, 298 Liver fibrosis, 282 Liver function, 31, 159 Liver lectin, 115 Liver resection, 266, 376 Liver transplantation, 16, 50, 73, 203, 351,

376 Liver tumors, 197 Liver volume, 159 Lymphoid cells, 380

Malignant ascites, 98 Membrane-associated proteins, 1 I Membrane lipids, 355 Membrane permeability, 38 Memory and naive T-lymphocytes, 197 Meta-analysis, 338 Micelle, 23 Microsomal function, 355 Mononuclear cells, 219 Multicentric carcinogenesis, 208 Multidrug resistance, 77

Multiple indicator dilution (MID) study, 38 Multiple regression analysis, 66

NANB chronic hepatitis, 184 Needle-stick injuries, 56 Neurology, 31 Neurophysiology, 31 Neuropsychology, 31 Neuroradiology, 31 Nitro blue tetrazolium, 266 Non-A, non-B hepatitis, 138 Nucleation time, 23

Obstructive jaundice, 171 Occupational diseases, 56 Octreotide, 320 Oleate, 304 Osteocalcin, 50

Paracellular pathway, 89 PCR, 224 PCR assay, 184 Perfused rat liver, 38, 77 Phenylalanine hydroxylase, l 1 P-glycoprotein, 77 Phorbol myristate acetate, 266 Plasma kallikrein, 115 Plasma membranes, 304 Pokeweed mitogen, 165 Polymerase chain reaction, 138 Polymorphonuclear cells, 98 Polymyxin B sulfate, 266 Polyneuropathy, 31 Portal hypertension, 338 Portal pressure, 355 Portal vein, flow velocity, 298 Post-transfusion hepatitis, 273 Posture, 190 Pre-core/core mutants, 224 Primary biliary cirrhosis, 165 Primary biliary cirrhosis and gender, 73 Procollagen Ili peptide, 282 Prognosis, 66 Prognosis factors, 66 Prolidase, 282 Prostaglandin E 2, 171 Protoporphyria, 203 Putrescine, 159 Pyuria, 73

Radioimmunoassay, 346 Rat liver, 115 Relaxation, 326 Respiratory quotient, 145 Restriction fragment length polymorphism,

316

Sex, 122 Shock-wave lithotripsy, 102 Sodium excretion, 190 Somatostatin, 128, 320 Spermidine, 159 Spermine, 159 Steatosis, 290

SUBJECT INDEX 399

Stereology, 355 Sulfonylurea. 215 Superoxide production, 17 I Survival, 290 Sweat test, 177 Systemic and splanchnic hemodynamics, 215

T-cell activation, 228 Tetraploid, 208 Thrombocytopenia, 16

Total parenteral nutrition, 145 Transplantation, 16 Tumor necrosing factor ~t, 376 Two-dimensional gel electrophoresis, I1

Ultrasound, 298 Unstirred water layer IUWL), 38

Variceal bleeding, 320 Vascular reactivity, 326

Vasopressin. 320 Verapamil. 77, 326 Vesicle, 23 Vincristine, 77 Viral replication. 380 Vitamin D, 50 Vitamin E. 332

Zinc sulphate, 282